AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Forward Pharmaceutical Science | Publishing Language: Chinese | Open Access

Progress of in situ bioimaging methods based on CRISPR/Cas9 system

Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
Show Author Information

Abstract

In situ bioimaging is a powerful tool for directly observing the localization, expression, and interactions of nucleic acids or protein targets within cells, providing essential insights into cell function and disease mechanisms. In recent years, the CRISPR/Cas9 system, a revolutionary gene-editing tool, has been applied to develop efficient in situ imaging techniques. This paper reviews recent CRISPR/Cas9-based imaging methods utilizing Cas9 protein, engineered single-guide RNA (sgRNA), and coupled fluorescent tags, and compares their application in living and fixed cells. It focuses on the specificity, signal amplification efficiency, and multi-modal imaging capabilities of these methods, with further discussion based on current research, aiming to offer a comprehensive overview of CRISPR/Cas9-based in situ bioimaging techniques, with some valuable reference and guidance for research in related fields.

CLC number: Q-334 Document code: A Article ID: 1000-5048(2025)-5-557-9

References

【1】
【1】
 
 
Journal of China Pharmaceutical University
Pages 557-565

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
ZHANG W, YIN W, FENG J, et al. Progress of in situ bioimaging methods based on CRISPR/Cas9 system. Journal of China Pharmaceutical University, 2025, 56(5): 557-565. https://doi.org/10.11665/j.issn.1000-5048.2025030302

467

Views

4

Downloads

0

Crossref

0

CSCD

Received: 03 March 2025
Published: 25 October 2025
© 2025 The Editorial Office of Journal of China Pharmaceutical University

This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/).